Hemophilia A
Roche wins patent appeal over Hemlibra, its hemophilia A drug, against Takeda’s Baxalta
Anika Sharma
In a patent dispute revolving around two competing hemophilia medications, Roche’s Genentech unit has achieved its second consecutive victory. Following ...
BioMarin R&D chief reveals two new pipeline candidates and strategy to sustain innovation
Anika Sharma
BioMarin, the California-based biotech giant, is embarking on a mission to create its most robust pipeline in history, with a ...
BioMarin’s Roctavian: FDA Approves Hemophilia A Gene Therapy with Positive Reception from Physician
SG Tylor
Source – BioMarin BioMarin’s Roctavian, a gene therapy for severe hemophilia A, has received FDA approval after initial rejection in ...
Altuviiio a weekly Administration Provides Effective Bleed Prevention for Severe Hemophilia A in Children
SG Tylor
Source – Sanofi On June 26, 2023, at the Annual Meeting of the International Society on Thrombosis and Haemostasis (ISTH) ...
